# Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)

> **NCT03423732** · PHASE2,PHASE3 · UNKNOWN · sponsor: **John Paul II Hospital, Krakow** · enrollment: 50 (actual)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **DRUG:** CardioCell
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03423732
- **Lead sponsor:** John Paul II Hospital, Krakow
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-19
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423732, "Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03423732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*